2022 Annual Meeting - Rectal Cancer Nonoperative Management: Tools for the Clinician to Enable Patient-Centered Decisions

Nonoperative management of rectal adenocarcinoma is an increasingly utilized treatment paradigm. Treatment entails short-course radiation therapy followed by chemotherapy or long-course chemoradiation with or without sequential chemotherapy. Expertise is required to identify suitable patients for nonoperative management, assess for clinical complete response and identify early signs of disease recurrence or progression. Effective implementation of a nonoperative treatment program requires interdisciplinary treatment and follow-up. This session will educate attendees on the data available for nonoperative management, the choice between long-course chemoradiation and short-course radiation plus chemotherapy, practical aspects regarding response assessment and monitoring, patient quality of life / rectal function after nonoperative management and the financial implications of treatment.

Target Audience

The activity is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, radiation physicists, radiation therapists, radiation dosimetrists, diagnostic radiologists and radiation oncology residents.

Learning Objectives

    Upon completion of this activity, participants should be able to:

    • Explain the current state of nonoperative management for rectal adenocarcinoma, including the implications of available preliminary data and the need for more follow-up.
    • Discuss the roles of the multiple interdisciplinary providers in the overall treatment paradigm of nonoperative management.
    • Implement a nonoperative management program (or identify needs prior to opening such a program) at their own institution, with understanding of expected risks and patterns of failure to inform patient-centered discussions.

     

    Course summary
    Available credit: 
    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.
    • 1.00 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

    Course opens: 
    10/23/2022
    Course expires: 
    12/01/2022
    Cost:
    $0.00
    Rating: 
    0

    Jeffrey Olsen, MD is employed at Department of Radiation Oncology, Memorial Hospital, University of Colorado, Aurora, CO and receives compensation/remuneration/funding from Syntactx.

    Anup Shetty, MD is employed at Washington University School of Medicine, St. Louis, MO and has no financial relationships with a commercial interest.

    Jon Vogel, MD is employed at Department of Surgery, University of Colorado School of Medicine, Aurora, CO and has no financial relationships with a commercial interest.

    Christopher Anker, MD is employed at Division of Radiation Oncology, University of Vermont Medical Center, Burlington, VT and receives compensation/remuneration/funding from Northern New England Clinical Oncology Society.

    Karyn Goodman, MD is employed at Icahn School of Medicine at Mount Sinai, Department of Radiation Oncology, New York, NY and receives compensation/remuneration/funding from Novartis, Philips Healthcare, RenovoRx, Roche/Genentech, and Syntactx.

    Hyun Kim, MD is employed at Washington University School of Medicine in St. Louis, Department of Radiation Oncology, St. Louis, MO and receives compensation/remuneration/funding from Hanbeam, Varian, ViewRay.

    The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

    Disclosure link: 
    Committee Disclosures

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

    ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

    Available Credit

    • 1.00 Certificate of Attendance
      This activity was designated for 1.00 AMA PRA Category 1 Credit™.
    • 1.00 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

    Price

    Cost:
    $0.00
    Please login or register to take this course.

    Policies: 
        • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
        • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
        • ASTRO staff cannot make modifications to your submitted materials.
     

    Required Hardware/software

    One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.